New Policies to Advance Development of Cell and Gene Therapies Announced by FDA

Author's Avatar
Jan 22, 2019
Article's Main Image

FDA Cites Increases in IND Submissions and Anticipated Product Approvals that could benefit BioLife Solutions

New Guidance to Support Manufacturing Process Changes for Late-Phase Developers Without Necessarily Requiring New Clinical Trials

PR Newswire